Anyone care to speculate as to Hepalink's slide the past few days? Down 4% on the trading day as I type. Completely dissociated from RVX? Presumption of long trial before payoff? Involvement of large BP diminishing Hepa's return?

Just curious. Hard to see how it could possibly be any negative perception of RVX's overall position, which is apparently stronger now than at any time in the last several months.

Thoughts?